TY - JOUR T1 - Induction of robust neutralizing antibodies against the COVID-19 Delta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with CoronaVac JF - medRxiv DO - 10.1101/2021.09.25.21264099 SP - 2021.09.25.21264099 AU - Samadhi Patamatamkul AU - Sutthiwan Thammawat AU - Benjaporn Buranrat Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/09/28/2021.09.25.21264099.abstract N2 - We determined the antibody response among CoronaVac vaccinees who were boosted with either BNT162b2 or ChAdOx1 nCoV-19. Increase in anti-S-RBD antibodies and surrogate neutralizing antibodies against the Delta variant was higher in BNT162b2 recipients than in ChAdOx1 nCoV-19 recipients. High proportions of reactogenicity were seen for both booster regimens.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Faculty of Medicine, Mahasarakham University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Mahasarakham University Ethics Committee approved the study. Informed consent was obtained before blood collection.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDatasets are available upon request. ER -